Oncolytics Biotech Inc. (ONCY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...

The stock market environment isn't as good as implied by the “regular new highs” booked by the S&P 500 index, as enthusiasm for artificial intelligence has helped investors ignore “tariff chaos,” the ...